The leadership of the Journal of Alzheimer's Disease has disclosed the following information in keeping with the journal's disclosure policy.
George Perry, PhD, Editor-in-Chief
Consultant/Advisory Boards: Alzheimer Research and Prevention Foundation, Nervgen, ACT-AD, Alzheimer Foundation of America, Investcure, Synaptogenix
Equity Ownership/Stock Options: Investacure, Neurotez, Neurotrope
Other: IOS Press (strategic advisor)
Beth Kumar, Managing Editor
Nothing to Disclose
Jesus Avila, MD, Deputy Editor
Nothing to Disclose
Daniela Galimberti, PhD, Deputy Editor
Nothing to Disclose
Paula Moreira, PhD, Deputy Editor
Nothing to Disclose
Massimo Tabaton, MD, Deputy Editor
Nothing to Disclose
Xiongwei Zhu, PhD, Deputy Editor
Nothing to Disclose
Madeleine Hackney, PhD, Reviews Editor
Nothing to Disclose
Dharma Singh Khalsa, MD, Prevention Editor
Consultant/Advisory Boards: President/Medical Director of Alzheimer's Research and Prevention Foundation
Allyson Rosen, PhD, ABPP-CN, Ethics Editor
Nothing to Disclose
Aaron A. Sorensen, Scientometrics Editor
Equity Ownership/Stock Options: emocha Mobile Health, Inc.
Last updated 10 June 2022
